Has Tanvir Bajwa, MD received payments from drug or device companies?

Yes. Drug and device makers reported $105,679 in general payments to Tanvir Bajwa, MD across 369 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tanvir Bajwa, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tanvir Bajwa, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tanvir Bajwa, MD

Interventional Cardiology · Milwaukee, WINPI 1740257385

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (35.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 90.0% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $25,344, 2.2 times the $11,563 reported in 2019. Among interventional cardiology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$105,679in general payments, 2019–2025

Across 369 payments — averaging $286.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$95K
Abbott$4K
Ancora Heart, Inc.$3K
Edwards Lifesciences$3K
Boston Scientific$363
Shockwave Medical, Inc$177
plus $447 from 5 others

$2,851,060in research payments, 2019–2025

Across 615 payments — averaging $4635.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$2.1M
Boston Scientific$512K
Abbott$181K
W. L. Gore & Associates, Inc.$91K
Daiichi Sankyo Inc.$7K
Zimmer Biomet$4K

What the payments were for

Consulting fees$24,11623%
Speaking & faculty fees$37,67336%
Grants$660%
Travel & lodging$31,55430%
Food & beverage$12,27012%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	299	$95,120
Abbott	34	$4,138
Ancora Heart, Inc.	7	$2,722
Edwards Lifesciences	18	$2,711
Boston Scientific	4	$363
Shockwave Medical, Inc	1	$177
Abiomed	1	$130
GE HealthCare	2	$112
ZOLL Medical Corporation	1	$97
Angiodynamics, Inc.	1	$89
Acist Medical Systems, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COREVALVE EVOLUT R$29,623
CoreValve Evolut$25,136
AccuCinch$2,712
TENDYNE$1,042
MitraClip$1,010
SAPIEN 3 Ultra RESILIA$647
Mitra Clip system$470
Edwards SAPIEN 3 Transcatheter Heart Valve$459
MitraClip System$334
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$271
APOLLOTM$257
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$177
WATCHMAN Access System$137
Apollo$118
GENERAL - STRUCTURAL HEART$115
TRICLIP$103

How this compares

$105,679 in reported general payments places this provider in the 95th percentile of 118 interventional cardiology providers in Wisconsin.

See all interventional cardiology providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$321,134

Medicare patients

1,055

Services billed

2,954

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	572	$676,306
Repatha SureclickEvolocumab	163	$136,764
EntrestoSacubitril/Valsartan	111	$118,783
XareltoRivaroxaban	90	$116,848
JardianceEmpagliflozin	82	$102,869
BrilintaTicagrelor	65	$66,875
Praluent PenAlirocumab	51	$29,214
ClopidogrelClopidogrel Bisulfate	1,256	$15,425
Repatha SyringeEvolocumab	16	$13,585
Metoprolol Succinate	757	$11,527
Atorvastatin Calcium	1,126	$10,816
Nitroglycerin PatchNitroglycerin	171	$7,160
Isosorbide Dinit-HydralazineIsosorbide Dinit/Hydralazine	36	$4,916
Nitroglycerin	278	$4,600
Metoprolol Tartrate	769	$4,565

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Milwaukee

Michael SalingerMilwaukee$216K
Suhail AllaqabandMilwaukee$88K
Saif AnwaruddinMilwaukee$80K
Iyad AzzamMilwaukee$60K
Montoya TaylorMilwaukee$48K
Mina IskanderMilwaukee$41K
Anna LarosaMilwaukee$38K
Louie KostopoulosMilwaukee$26K
Daniel JohnsrudMilwaukee$25K
Sasanka JayasuriyaMilwaukee$15K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →